Peter V. Robinson
Impact in
-
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Genetics 4
- Diabetes and associated disorders 4
- Co-authors
- Carolyn R. Bertozzi (6 shared papers)Cheng‐ting Tsai (9 shared papers)Julia L. McKechnie (2 shared papers)Amber E. de Groot (2 shared papers)David Seftel (8 shared papers)Carole A. Spencer (1 shared paper)Felipe de Jesus Cortez (5 shared papers)Mark Pandori (2 shared papers)
- Journals
- Journal of the American Chemical Society (2 papers)SLAS TECHNOLOGY (2 papers)Scientific Reports (1 paper)Transfusion (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesIsraelSweden
In The Last Decade
Peter V. Robinson
12 papers receiving 338 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 59
- Gastroenterology 16
- Molecular Biology 183
- Organic Chemistry 69
- Genetics 61
Countries citing papers authored by Peter V. Robinson
This map shows the geographic impact of Peter V. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Robinson more than expected).
Fields of papers citing papers by Peter V. Robinson
This network shows the impact of papers produced by Peter V. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Robinson. The network helps show where Peter V. Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter V. Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 71 | |
| 2 | 2016 | 56 | |
| 3 | 2016 | 54 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 34 | |
| 6 | 2020 | 30 | |
| 7 | 2020 | 21 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 3 | |
| 11 | 2016 | 3 | |
| 12 | 2024 | 2 |
About Peter V. Robinson
Peter V. Robinson is a scholar working on Molecular Biology, Genetics, Infectious Diseases, Surgery and Oncology, having authored 12 papers that have together received 351 indexed citations. Recurring topics across this work include Diabetes and associated disorders (4 papers), Glycosylation and Glycoproteins Research (3 papers), Pancreatic function and diabetes (3 papers), Diabetes Management and Research (2 papers), SARS-CoV-2 detection and testing (2 papers), Peptidase Inhibition and Analysis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (59 citations), Gastroenterology (16 citations), Molecular Biology (183 citations), Organic Chemistry (69 citations) and Genetics (61 citations). Peter V. Robinson has collaborated with scholars based in United States, Israel and Sweden. Frequent co-authors include Carolyn R. Bertozzi, Cheng‐ting Tsai, Julia L. McKechnie, Amber E. de Groot, David Seftel, Carole A. Spencer, Felipe de Jesus Cortez, Mark Pandori, David M. Maahs and Darrell M. Wilson. Their work appears in journals such as Journal of the American Chemical Society, SLAS TECHNOLOGY, Scientific Reports, Transfusion and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.